blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3099289

EP3099289 - COMPOSITION COMPRISING EPA AND DHA TRIGLYCERIDES FOR PARENTERAL ADMINISTRATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  21.02.2020
FormerGrant of patent is intended
Status updated on  08.10.2019
FormerExamination is in progress
Status updated on  03.11.2017
FormerRequest for examination was made
Status updated on  04.11.2016
Most recent event   Tooltip19.12.2025Lapse of the patent in a contracting state
New state(s): TR		published on 21.01.2026  [2026/04]
Applicant(s)For all designated states
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
[2020/13]
Former [2016/49]For all designated states
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
Inventor(s)01 / BRITO DE LA FUENTE, Edmundo
Breslauer Ring 50
61381 Friedrichsdorf / DE
02 / GALLEGOS-MONTES, Crispulo
Frankfurter Landstrasse 160
61352 Bad Homburg / DE
03 / QUINCHIA-BUSTAMENTE, Lida A.
Wiesenstrasse 5
61352 Bad Homburg / DE
 [2016/49]
Representative(s)Fresenius Kabi Deutschland GmbH
Patent Department
Pharmaceuticals Division
Borkenberg 14
61440 Oberursel / DE
[2020/13]
Application number, filing date15703511.428.01.2015
[2016/49]
WO2015EP51657
Priority number, dateEP2014015278528.01.2014         Original published format: EP 14152785
[2016/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015113987
Date:06.08.2015
Language:EN
[2015/31]
Type: A1 Application with search report 
No.:EP3099289
Date:07.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 06.08.2015 takes the place of the publication of the European patent application.
[2016/49]
Type: B1 Patent specification 
No.:EP3099289
Date:25.03.2020
Language:EN
[2020/13]
Search report(s)International search report - published on:EP06.08.2015
ClassificationIPC:A61K9/00, A61K9/107, A61K47/10, A61K47/12, A61K47/24, A61K31/232, A23L33/12
[2019/42]
CPC:
A61K31/232 (EP,US); A23L33/12 (EP,US); A61K47/10 (EP,US);
A61K47/12 (EP,US); A61K47/24 (EP,US); A61K9/0029 (EP,US);
A61K9/107 (EP,US) (-)
C-Set:
A61K31/232, A61K2300/00 (EP,US)
Former IPC [2016/49]A61K9/00, A61K47/10, A61K47/12, A61K47/24, A61K9/107, A61K31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNG MIT EPA- UND DHA-TRIGLYCERIDEN ZUR PARENTERALEN VERABREICHUNG[2016/49]
English:COMPOSITION COMPRISING EPA AND DHA TRIGLYCERIDES FOR PARENTERAL ADMINISTRATION[2016/49]
French:COMPOSITION COMPRENANT DES TRIGLYCÉRIDES EPA ET DHA POUR ADMINISTRATION PARENTÉRALE[2016/49]
Entry into regional phase04.08.2016National basic fee paid 
04.08.2016Designation fee(s) paid 
04.08.2016Examination fee paid 
Examination procedure04.08.2016Examination requested  [2016/49]
04.08.2016Date on which the examining division has become responsible
10.05.2017Amendment by applicant (claims and/or description)
07.11.2017Despatch of a communication from the examining division (Time limit: M06)
22.06.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
17.08.2018Reply to a communication from the examining division
05.02.2019Despatch of a communication from the examining division (Time limit: M04)
23.05.2019Reply to a communication from the examining division
09.10.2019Communication of intention to grant the patent
18.02.2020Fee for grant paid
18.02.2020Fee for publishing/printing paid
18.02.2020Receipt of the translation of the claim(s)
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
17.08.2018Request for further processing filed
17.08.2018Full payment received (date of receipt of payment)
Request granted
05.09.2018Decision despatched
Fees paidRenewal fee
10.01.2017Renewal fee patent year 03
17.01.2018Renewal fee patent year 04
16.01.2019Renewal fee patent year 05
15.01.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.01.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MK25.03.2020
MT25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
TR25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
[2026/04]
Former [2024/41]HU28.01.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MK25.03.2020
MT25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2024/22]HU28.01.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MK25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2023/30]HU28.01.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2023/27]HU28.01.2015
AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/40]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/24]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/10]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/09]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/08]CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/50]CZ25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/49]CZ25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/48]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/47]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/46]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/45]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/39]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/38]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
GR26.06.2020
Former [2020/37]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
Former [2020/35]FI25.03.2020
NO25.06.2020
Cited inInternational search[XI] CN102512367  (XI AN LIBANG PHARMACEUTICAL CO LTD et al.) [X] 1,4-6,8,10-18 * examples 12,13 *[I] 2,3,7,9
 [XI] CN102552328  (YUWANG PHARMACEUTICAL CO LTD et al.) [X] 1-6,8-18 * page 8, line 11 to page 10, line 24;; examples 1-5 *[I] 7
 [XA] US5874470  (NEHNE JOERG et al.) [X] 11-18 * examples 2,4 *[A] 1-10
 [XDA] WO2010104575  (STABLE SOLUTIONS LLC et al.) [XD] 11-18 * table 1 *[A] 1-10
 [A]   F. S. H. LU ET AL: "Physico-chemical Properties of Marine Phospholipid Emulsions", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 89, no. 11, 7 July 2012 (2012-07-07), pages 2011 - 2024, XP055119375, ISSN: 0003-021X, DOI: 10.1007/s11746-012-2105-z [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1007/s11746-012-2105-z
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.